rubraca
pharmaand gmbh - rucaparib camsylate - ovariálne nádory - antineoplastické činidlá - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca je označené ako monotherapy pre udržiavaciu liečbu dospelých pacientov s platinum-citlivé relapsed high-grade epitelové vaječníkov, fallopian trubice, alebo primárne peritoneal rakovine, ktorí sú v reakcii (úplné alebo čiastočné) platinum-založené chemoterapia.
bisocard 5 mg
bausch health ireland limited, Írsko - bisoprolol - 41 - cardiaca
bisocard 10 mg
bausch health ireland limited, Írsko - bisoprolol - 41 - cardiaca
flutasin 250 mg
actavis group ptc ehf. - flutamid - 44 - cytostatica
spiromon 5 mg žuvacie tablety
zentiva, k.s., Česká republika - montelukast - 14 - bronchodilatantia, antiasthmatica
spiromon 4 mg žuvacie tablety
zentiva, k.s., Česká republika - montelukast - 14 - bronchodilatantia, antiasthmatica
asolfena 5 mg
krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica
asolfena 10 mg
krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica
solasfera 10 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica
solasfera 5 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica